Grant Funding Opportunities: 11/15/2013
Weekly Grant Funding Opportunities
Please feel free to send special funding search requests any time (susan_craft@ncbiotech.org). Please note that beginning July 1, 2013, grant funding requests will be rolled into our regular research and will include a fee of $100/hour. Also, let us know if any of your partners have submitted grant applications to funding announcements posted in the weekly grant alert emails. We would love to hear of their successes!
Visit NCBiotech’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases and grant development tips.
Grant Opportunities
Deadline: 11/21/2013
Agency: Alzheimer's Drug Discovery Foundation
Program: ApoE Therapeutics Program
Description: The Alzheimer's Drug Discovery Foundation funds drug discovery and development research programs in the field of Alzheimer's disease, related dementias, and cognitive aging. ADDF and the Robert A. and Renée E. Belfer Family Foundation established the ADDF/Belfer ApoE Therapeutics Innovation Program to accelerate the development of novel therapeutics specifically designed to target ApoE pathological mechanisms. This Request for Proposals will support both preclinical and clinical stage programs.
Award Amount: $300,000 - 1,000,000
Website: www.alzdiscovery.org/assets/content/static/2013_ApoE_RFP_FINAL.pdf
Eligibility: Applications may be submitted by nonprofit academic institutions and for-profit biotechnology companies, both public and private, worldwide.
Deadline: 11/21/2013
Agency: National Science Foundation
Program: NSF Science, Engineering and Education for Sustainability Fellows
Description: Through the SEES Fellows Program, NSF seeks to advance science, engineering, and education to inform the societal actions needed for environmental and economic sustainability and human well-being while creating the necessary workforce to address these challenges. The Program's emphasis is to facilitate investigations that cross traditional disciplinary boundaries and address issues of sustainability through a systems approach, building bridges between academic inquiry, economic growth, and societal needs. The Fellow's proposed investigation must be interdisciplinary and allow him/her to obtain research experiences beyond his/her current core disciplinary expertise. Fellows are required to develop a research partnership(s) that will advance and broaden the impact/scope of the proposed research, and present a plan for their own professional development in the area of sustainability science and engineering. Proposals with a primary focus on topics covered by the Directorate for Engineering (ENG) are considered "out of scope" for this revised solicitation; however, proposals may include such topics as a secondary (or tertiary) focus.
Award Amount: Varies
Website: www.grants.gov/web/grants/view-opportunity.html?oppId=241323
Eligibility: Universities; Colleges; Nonprofit, non-academic organizations; For-profit organizations; Unaffiliated individuals
Deadline: 11/25/2013
Agency: Dept. of the Army -- USAMRAA
Program: DoD Gulf War Illness Clinical Trial Award with Multiple-PI Option
Description: The FY13 GWIRP is offering two award mechanisms to evaluate potential interventions for Gulf War Illness: the Clinical Trial Award (CTA) and the Innovative Treatment Evaluation Award (ITEA). The Clinical Trial Award, described in this Program Announcement/Funding Opportunity, is intended to support larger, more definitive (Phase II-III, FDA device class I-III) clinical trials. In contrast, the ITEA supports the initial evaluation of a treatment or intervention in smaller, early phase or pilot clinical trials (Phase II or I/II), and does not require preliminary data. (For information about the ITEA, see http://cdmrp.army.mil/funding/gwirp.shtml.) The CTA mechanism was first offered in FY08. Since then, nine Clinical Trial Award applications have been received, and three have been recommended for funding. The CTA supports execution of clinical trials with the potential to have a significant impact on the health and lives of veterans with GWI. Health outcomes of interest should include effects of interventions on: Global health measures (biomarkers) and/or functional status; Improvements in symptom complexes (e.g., cognitive function, musculoskeletal/pain symptoms, gastrointestinal symptoms, fatigue, respiratory problems, skin abnormalities, sleep difficulties), individually and as they may interact with each other; GWI subgroups characterized by symptom or other clinical characteristics New for FY13: The CTA can be used for comparative research of GWI treatments and multi-center trials comparing treatments. Such studies can be executed by a team of investigators led by an Initiating Principal Investigator (PI) with up to three Partnering PIs.
Award Amount: Varies
Website: www.grants.gov/web/grants/view-opportunity.html?oppId=237504
Eligibility: Unrestricted
Deadline: 12/2/2013
Agency: National Science Foundation
Program: Small Business Innovation Research Program Phase I Solicitation FY-2014 (SBIR)
Description: The Small Business Innovation Research (SBIR) Program stimulates technological innovation in the private sector by strengthening the role of small business concerns in meeting Federal research and development needs, increasing the commercial application of federally supported research results, and fostering and encouraging participation by socially and economically disadvantaged and women-owned small businesses. The SBIR program solicits proposals from the small business sector consistent with NSF's mission. The program is governed by Public Law 112-81 (SBIR/STTR Reauthorization Act of 2011). A main purpose of the legislation is to stimulate technological innovation and increase private sector commercialization. The NSF SBIR program is therefore in a unique position to meet both the goals of NSF and the purpose of the SBIR legislation by transforming scientific discovery into both social and economic benefit, and by emphasizing private sector commercialization. Accordingly, NSF has formulated broad solicitation topics for SBIR that conform to the high-technology investment sector's interests. The topics, listed below, are detailed on the SBIR/STTR topics homepage: Educational Technologies and Applications (EA); Information and Communication Technologies (IC); Semiconductors (S) and Photonic (PH) Devices and Materials; Electronic Hardware, Robotics and Wireless Technologies (EW); Advanced Manufacturing and Nanotechnology (MN); Advanced Materials and Instrumentation (MI); Chemical and Environmental Technologies (CT); Biological Technologies (BT); Smart Health (SH) and Biomedical (BM) Technologies.
Award Amount: $150,000.00
Website: www.nsf.gov/pubs/2013/nsf13599/nsf13599.htm
Eligibility: Small businesses
Deadline: 12/5/2013
Agency: Alzheimer's Drug Discovery Foundation
Program: General Request for Proposals
Description: The Alzheimer’s Drug Discovery Foundation (ADDF) funds drug discovery and development research programs in the field of Alzheimer’s disease (AD), related dementias and cognitive aging. The ADDF seeks to fill the critical translational funding gap between basic research and later stage drug development by funding promising drug discovery and development programs. In addition to funding academic programs, the ADDF also invests in and creates early stage biotechnology companies. The ADDF also co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the Foundation. The ADDF funds four different categories of research: Drug Discovery (target validation; highthroughput screening; medicinal chemistry, including hit to lead development and lead optimization; in vitro and in vivo studies of efficacy, ADME, toxicology, pharmacokinetics and pharmacodynamics; and in vivo proof-of-concept with lead compounds and biologics), Early Detection (development of biomarkers to accelerate drug development and early diagnosis), Clinical Trials (innovative pilot clinical trials) and Prevention (targeted pharmacological and non-pharmacological approaches to prevention). The ADDF accepts Letters of Intent (LOIs) for the “General Request for Proposals” research award programs throughout the year. 2013 deadlines for full proposals are January 22, March 5, June 5, September 5 and December 5. LOIs are due at least two weeks prior to the proposal deadlines.
Award Amount: $150,000.00
Website:www.alzdiscovery.org/assets/content/static/2013_General_RFP_AND_Funding_Priorities_for_display.pdf
Eligibility: Academic medical centers and universities; private early-stage biotech companies